Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Clobetasol propionate topical preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Clobetasol propionate 500 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Clobetasol propionate 0.05% scalp application |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Clobetasol propionate 500 microgram/g cutaneous foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Clobetasol propionate 500 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Clobetasol propionate 500 microgram/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Clobetasol propionate emollient 0.05% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Clobetasol propionate 500 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clobetasol propionate |
Inferred relationship |
Some |
|
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/g cutaneous foam |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/g cutaneous foam |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/mL cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/mL cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Clobetasol propionate 500 microgram/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Product containing precisely clobetasol propionate 500 microgram/1 gram and gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |
Product containing precisely clobetasol propionate 500 microgram/1 gram and gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clobetasol propionate |
Inferred relationship |
Some |
1 |